The current study was conducted to compare DNA yield, including normalization to nuclear area, DNA amplification functionality, and detection of KRAS mutations between matched fine-needle aspiration (FNA) specimens and pancreatic resections diagnostic of pancreatic ductal adenocarcinoma. METHODS: A retrospective sample of 30 matched single FNA smears and macrodissected formalin-fixed, paraffin-embedded (FFPE) curls (2 5-lm curls) were compared by measuring the following: nuclear area (via digital image analysis), DNA yield (via NanoDrop spectrophotometry and Quantus fluorometry), and polymerase chain reaction threshold cycles for KRAS amplifications. Variants in KRAS codons 12/13 and 61 were detected by fluorescent melt curve analyses, followed by Sanger DNA sequencing. RESULTS:
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with an overall 5-year survival rate of <10%, and currently is the fourth leading cause of death in men and women. 1 PDAC is routinely diagnosed via endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA), which is the recommended first-line technique. 2 Only approximately 20% of patients are eligible for surgical resection after the initial diagnosis. 3 As such, PDAC encountered in routine surgical pathology practice represents only 20% of disease, whereas cytologic EUS-FNA material represents resectable and unresectable disease. Therefore, EUS-FNA material diagnostic of PDAC is an important repository for molecular testing in the ongoing search for predictive biomarkers.
To our knowledge to date, molecular testing is not performed routinely on FNA or formalin-fixed, paraffin-embedded (FFPE) material diagnostic of PDAC. However, there is a drive to develop targeted therapies that would require the routine molecular testing of PDAC samples. The 2014 National Cancer Institute working group tasked with developing a scientific framework for supporting research on PDAC called for the development of treatments that interfere with RAS oncogene pathways. 4 Promising advances in this area include the development of nanoparticles that deliver small interfering RNA (siRNA) targeting KRAS. 5, 6 KRAS mutation is the most commonly acquired mutation identified in patients with PDAC, with reported rates of >90%. 3 The majority of mutations occur at KRAS codons 12 and 13. The frequency of the KRAS mutation, combined with the fact that the majority of resected PDACs have EUS-FNA diagnostic material, make targeted amplification of KRAS in PDAC an ideal model for comparing the molecular testing of matched FNA and FFPE samples. PDAC material derived from EUS-FNA will become increasingly important as the molecular landscape of PDAC and associated therapies continues to develop. Because cytology samples, including direct smears, are increasingly being used for molecular testing, 7 we sought to contribute to the growing body of literature comparing FNA with FFPE adequacy for mutation detection. The trend toward increasing the use of FNA specimens for ancillary molecular tests is bolstered by a 2013 change to the College of American Pathologists Cytopathology Accreditation Checklist allowing for the use of FNA glass slides for diagnostic purposes, as an exception to the Slide Retention checklist item (CYP .06900). 8 To our knowledge, only 3 previous studies have compared matched FNA and FFPE material diagnostic of PDAC. [9] [10] [11] Only 1 of these 3 used FNA direct smears, 9 whereas the other studies 10, 11 used FNA cell block material.
The objectives of the current study were to: 1) compare the DNA yields of single Diff-Quik FNA specimens and macrodissected FFPE Whipple resection curls (2 curls measuring 5 lm each) with 2 widely used DNA quantification methods (NanoDrop spectrophotometry [ThermoFisher Scientific, Waltham, Massachusetts] and Quantus fluorometry[Promega Corporation, Fitchburg, Wisconsin]), and normalize to nuclear area; 2) compare the amplification functionality of FNA versus FFPE-derived DNA via cycle thresholds in polymerase chain reactions (PCRs); and 3) compare the overall concordance of KRAS mutations detected in matched FNA and FFPE material.
MATERIALS AND METHODS
The study was conducted as a quality improvement project and, as such, institutional review board review was not required. Thirty cases with matched FNA and FFPE material diagnostic of PDAC were identified in the archives of the pathology department of the University of Wisconsin Hospital and Clinics between 2011 and 2015.
Single, Diff-Quik-stained FNA specimens and hematoxylin and eosin (H&E)-stained FFPE levels with diagnostic material were imaged on the Leica ScanScope (Leica Biosystems, Wetzlar, Germany) (Fig. 1A) . Image analysis was performed using ImageJ software. 12 On the H&E-stained slides, areas with a high tumor percentage were circled for subsequent image analysis and macrodissection before DNA extraction. The blue/purple spectrum of nuclei on FNA and H&E then were selected out from the background and measured using YUV color thresholding (Fig. 1C) . Occasionally, dense blood on FNA smears and dense acellular collagen on H&E slides would register falsely as nuclei via color thresholding, and manual whiting-out of those areas was performed (Fig. 1B) . Nuclear area (in mm 2 ) was defined as the 2-dimensional area of the scaled image after color thresholding to select for nuclei, and was measured on all FNA specimens and H&E-stained blocks. Tumor percentage was determined by manual review of FNA samples and H&E-stained slides.
Two unstained, 5-lm FFPE curls were macrodissected, with tumor-rich areas identified in correlation with the previously marked H&E-stained levels. DNA extraction was performed using the Promega Maxwell CSC DNA FFPE Kit (Promega Corporation) according to manufacturer's instructions. Briefly, paraffin was removed from FFPE tissue samples with mineral oil, followed by decrosslinking of nucleic acids in the presence of proteinase K and lysis buffer for 4 hours at 80 8C. Entire air-dried Diff-Quik-stained FNA specimens (positively charged glass slides) were scraped and processed in the same manner as FFPE material after removal of the coverslips with xylene.
Once extracted, DNA concentrations were measured using NanoDrop spectrophotometry (ThermoFisher Scientific) and Quantus fluorometry (Promega Corporation) as per the manufacturers' instructions.
Coamplification at lower denaturation temperaturereal-time PCR (COLD-PCR) 13 was used to amplify the DNA amplification functionality was defined by the threshold cycles of the 2 separate PCR reactions, with a lower number of threshold cycles indicating a better DNA amplification functionality. Bidirectional Sanger sequencing using BigDye Terminator v3.1 on an ABI 3500 (Applied Biosystems ThermoFisher Scientific, Foster City, California) was conducted to identify variants at codons 12, 13, and 61 of KRAS in the real-time PCR amplification products according to the manufacturer's specifications.
Statistical Analysis
Continuous variables were compared between the FNA and FFPE groups using the Mann-Whitney U test and the Kruskal-Wallis test due to the small sample size and skewed distributions. Bivariate ordinary least squares linear regression was used to compare 2 independent variables (NanoDrop DNA yield in ng/mL and FNA or FFPE specimen type [binary design variable]) with the dependent variable Quantus DNA yield (in ng/mL). Pearson correlation was used to compare the correlations of nuclear area to DNA yield and PCR threshold cycles. Because this was a quality improvement project, patient demographic information, including survival, was not collected or analyzed.
All statistical analyses were performed using R statistical software (version 3.3.1; R Foundation, Vienna, Austria) with the R commander graphical user interface. 14 
RESULTS

Samples
In 29 cases, the samples represented preresection EUS-FNA sampling and Whipple resection FFPE specimens. In 1 case, the EUS-FNA specimen was from a recurrence in the surgical resection bed, and because the Whipple resection sample was not available for review, FFPE material from a concurrent core needle biopsy specimen was used. The tumor percentage in submitted material approached 100% for all FFPE specimens because tumor-rich blocks could be selected for every case. For FNA samples, the tumor percentage ranged from 5% to 90% (mean, 52.2%); 6 smears had a tumor percentage of 25%, with the remaining 24 specimens demonstrating a tumor percentage of 30%.
Original Article (Fig. 1D ). FNA and FFPE PDAC specimens were found to demonstrate comparable threshold cycles for both KRAS 12/13 and KRAS 61 (Table 1) , indicating comparable amplification functionality.
KRAS Mutation Detection and FNA-FFPE Concordance
A total of 23 KRAS 12 mutations were detected in 30 FNA specimens (77%), compared with 17 of 30 mutations (57%) in the matched FFPE specimens (Table 2) . Representative melt curves and Sanger sequencing chromatograms are presented in Figure 3 . We detected a KRAS 12 mutation that, to our knowledge, has not been reported in PDAC previously, namely Gly12Pro. This novel mutation was detected in both the forward and reverse Sanger sequences in both the FNA and matched FFPE samples. For cases with KRAS 12 mutations in FNA and FFPE material, the genotypes were concordant, and were detected in independent bidirectional sequencing reactions. No KRAS 13 or 61 mutations were detected. Comprehensive paired FNA and FFPE results are presented in Table 3 . Input DNA by fluorometry was not found to be statistically different between FFPE and FNA material with and without mutations detected (P 5 .06, KruskalWallis test) (Fig. 4) . The median DNA for the groups was as follows: FFPE negative (13 samples 
DISCUSSION
FNA specimens are regarded as superior to FFPE material in several ways. Direct smears are not formalin-fixed, and retain whole nuclei, thereby providing DNA of higher quality and quantity. 15 In terms of processing, air-dried Diff-Quik-stained smears are easier to prepare and microdissect compared with cell blocks or FFPE counterparts. 16 The FNA technique also samples a wide area of tumor due to the multidirectionality of passes, and often has less contamination by stromal tissue. 16 The disadvantages of FNA samples as a source of DNA include the fact that the slide must be destroyed to submit cellular material for DNA extraction. In 2013, the College of American Pathologists updated the Cytopathology Accreditation Checklist to allow for the use of FNA smear glass slides for diagnostic purposes. 8 To address the loss of diagnostic material, we selected cases with >1 diagnostic direct smear, and stored whole-slide images in a digital archive. The adequacy of FNA specimens for molecular testing has been well established and is best studied in thyroid neoplasms, lung adenocarcinoma, and metastatic melanoma using a variety of platforms, including high-resolution melt curve analysis, allele-specific PCR, Sanger sequencing, pyrosequencing, and next-generation sequencing. [17] [18] [19] [20] [21] [22] In the case of lung adenocarcinoma, FNA smears have been shown to have DNA amplification functionality superior to that of biopsies, resection FFPE, and FNA cell block FFPE on a next-generation sequencing platform. 23 To the best of our knowledge, few studies to date have evaluated air-dried FNA samples of PDAC for molecular testing, 9,24 although many more have evaluated dedicated passes and/or FNA cell block FFPE material (Table 4) . [9] [10] [11] [24] [25] [26] [27] [28] [29] [30] [31] [32] The current study of KRAS in PDAC compares what to our knowledge is the largest number of paired FNA smears and resection FFPE specimens to date, and is the only study to demonstrate concordance of <100% (Table 4) . [9] [10] [11] [24] [25] [26] [27] [28] [29] [30] [31] [32] It is interesting to note that the entire FNA smear need not be scraped as in the current study, because dissection of tumor-rich areas can be performed. In what to the best of our knowledge are the 2 other studies to date that have extracted DNA from direct smears of PDAC FNA material, Gleeson et al scraped the entire slide, and de Biase et al did not specify how much of the slide they scraped.
9,24
The metrics we used captured a variety of similarities and differences between FNA and FFPE PDAC samples. Similarities included nuclear area in the submitted material, amplification functionality (as defined by PCR threshold cycles), and Quantus DNA yield per NanoDrop DNA yield. The latter indicates a comparable background signal in the known overestimation of DNA quantity by NanoDrop spectrophotometry, due to ultraviolet-absorbing contaminants such as RNA and proteins, in the range of 260 nm. 33 Important differences between FNA and FFPE PDAC specimens include greater DNA per nuclear area in FNA, and a higher rate of mutation detection in FNA despite a lower tumor percentage. At 77%, the overall KRAS mutation detection rate in the current study is slightly lower than the wellestablished rate of 90%, but similar to the rate of detection in FNA material reported in prior studies (61%-100%) ( Table 4) . [9] [10] [11] [24] [25] [26] [27] [28] [29] [30] [31] [32] Sanger sequencing is reliable for the detection of mutations at an allele frequency of approximately30% in a background of normal alleles. 13, 34 In the current study, the use of COLD-PCR enhanced the sensitivity for KRAS 12/13 mutations. COLD-PCR has been shown to enhance sensitivity for mutation detection in Sanger sequencing by 5-fold to 13-fold, depending on the mutation. 34 In our laboratory, we have reliably detected mutations with an allele frequency of 5% to 10% with COLD-PCR. Our KRAS 61 PCR reaction was unbiased, and subsequent Sanger sequencing was expected to detect mutations present at an allele frequency of approximately 30%. The sensitivity for mutation detection is most limited when the percentage of tumor in a specimen is below the allele frequency threshold. However, of the FNA smears with a tumor percentage of 30% (7 samples; range 5%-30%), KRAS 12 mutations were detected in all samples except for one with a tumor percentage of 20%, which was the only possible falsenegative result in this regard. Lack of detection of expected KRAS 12 mutations in FFPE Whipple resection material with a much higher tumor percentage (all approaching 100%) and a comparable amount of input DNA suggests a major limitation of FFPE PDAC material. In particular, there were 2 paired cases in which the FFPE had a higher fluorometric DNA yield than the scraped FNA sample, but the mutation was detected only in the smear material and not in the FFPE (Cases 5 and 6, Table 3 ). The cycle thresholds in these cases for the KRAS 12/13 and KRAS 61 PCR reactions confirmed that the KRAS DNA was present and successfully amplified, but no mutation was detected.
A strength of the current study, in terms of clinical relevance, is the use of limited material (eg, single FNA smears and only 2 5-lm FFPE curls), yielding relatively low amounts of DNA compared with studies that have sought to demonstrate a proof of principle for FNA smears as a source of DNA for molecular testing. This is similar to the amount of material our laboratory submits for molecular analysis of FNA and FFPE for clinical use (eg, BRAF testing on melanoma FFPE tissue or thyroid FNA specimens). Gleeson et al demonstrated 100% concordance between FNA and FFPE PDAC specimens, but excluded all cases with a yield of <5 ng/mL of DNA by Qubit fluorometry. 9 If we used the same exclusion criterion, we would have excluded 25 of 30 FNA specimens and 28 of 30 FFPE specimens. Conversely, the use of limited material restricts our sensitivity for mutation detection, particularly in the unbiased KRAS 61 PCR amplification. Despite similar and low DNA yields in our FNA and FFPE material, FNA was the gold standard in the current study: 6 KRAS mutations detected in FNA samples failed to be detected in matched FFPE tissue (Table 3) . This observation, combined with the fact that FNA and FFPE DNA demonstrated comparable DNA amplification functionality (similar threshold cycles in the 2 PCR reactions) indicates that the mutant allele frequency was lower in the FFPE material, possibly due to tumor heterogeneity or because mutant alleles are preserved more poorly in FFPE material compared with FNA specimens. Future studies could evaluate whether the lack of detection of a mutation in FFPE compared with preresection FNA material represents a molecular response to therapy.
The greater yield of DNA per nuclear area of scraped FNA specimens compared with FFPE material in the current study raises concerns regarding the comparability of smears that focally can be as thick as 30 lm 35 and 2 macrodissected 5-lm curls (10 lm in total). Unfortunately, to the best of our knowledge, it is impossible to determine the average thickness of FNA specimens, but it may exceed 10 lm. Nonetheless, our 2-dimensional morphometric analysis provided a measure of the amount of nuclear material submitted for DNA extraction. Because of possible concerns regarding the thickness of FNA smears, or the morphometric methodology itself, we included comparisons of DNA mutation detection according to input DNA not normalized to nuclear area. Despite similar input DNA (not normalized to the nuclear area) and a higher tumor percentage, FFPE DNA yielded an inferior rate of mutation detection. Of course, input DNA from FFPE could be increased by submitting additional curls for DNA extraction. Nonetheless, the findings of the current study support that FNA smears are superior with a given amount of DNA from each source. The amount of input DNA did not appear to differ significantly between FNA and FFPE material with and without mutations (Fig. 4) , but the rate of mutation detection was superior in scraped FNA smears ( Table 2) .
The results of the current study confirm prior evidence supporting a preference for scraped FNA Diff-Quik smears over limited FFPE material for molecular testing. This preference is especially relevant in the molecular analysis of PDAC because there often is extensive fibrosis or neoadjuvant treatment response at the time of surgical resection. 
Conclusions
The current study findings demonstrate that KRAS detection and DNA yield per nuclear area are superior in single FNA specimens compared with single macrodissected FFPE blocks (2 curls measuring 5 lm each). The fact that comparable yields of DNA between FNA and FFPE material resulted in such different rates of mutation detection suggests that FFPE requires more input DNA than direct FNA smears. In the nascent clinical application of molecular analysis of PDAC for prognosis and therapy selection, FNA material often is the sole diagnostic material, but is preferable to resection FFPE tissue even if available.
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